Stevanato Group Gelecekteki Büyüme

Future kriter kontrolleri 3/6

Stevanato Group kazanç ve gelirin sırasıyla yıllık 20.3% ve 8% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 19.8% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 11.5% olacağı tahmin edilmektedir.

Anahtar bilgiler

20.3%

Kazanç büyüme oranı

19.8%

EPS büyüme oranı

Life Sciences kazanç büyümesi18.4%
Gelir büyüme oranı8.0%
Gelecekteki özkaynak getirisi11.5%
Analist kapsamı

Good

Son güncelleme21 Nov 2024

Gelecekteki son büyüme güncellemeleri

Stevanato Group S.p.A. Just Missed Earnings - But Analysts Have Updated Their Models

Nov 08
Stevanato Group S.p.A. Just Missed Earnings - But Analysts Have Updated Their Models

Stevanato Group S.p.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 12
Stevanato Group S.p.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Recent updates

Stevanato: Supportive Biopharmaceutical And Diagnostic Segment And Destocking Improvement

Nov 13

Stevanato Group's (NYSE:STVN) Anemic Earnings Might Be Worse Than You Think

Nov 12
Stevanato Group's (NYSE:STVN) Anemic Earnings Might Be Worse Than You Think

Stevanato Group S.p.A. Just Missed Earnings - But Analysts Have Updated Their Models

Nov 08
Stevanato Group S.p.A. Just Missed Earnings - But Analysts Have Updated Their Models

We Think Stevanato Group (NYSE:STVN) Is Taking Some Risk With Its Debt

Oct 23
We Think Stevanato Group (NYSE:STVN) Is Taking Some Risk With Its Debt

Is Stevanato Group S.p.A. (NYSE:STVN) Worth US$19.3 Based On Its Intrinsic Value?

Aug 21
Is Stevanato Group S.p.A. (NYSE:STVN) Worth US$19.3 Based On Its Intrinsic Value?

Stevanato Group S.p.A. (NYSE:STVN) Looks Just Right With A 28% Price Jump

Jul 25
Stevanato Group S.p.A. (NYSE:STVN) Looks Just Right With A 28% Price Jump

Does Stevanato Group (NYSE:STVN) Have A Healthy Balance Sheet?

Jul 23
Does Stevanato Group (NYSE:STVN) Have A Healthy Balance Sheet?

Stevanato: Destock Pressures, Long-Term Upside

May 29

Stevanato Group S.p.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 12
Stevanato Group S.p.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Stevanato Group S.p.A.'s (NYSE:STVN) Share Price Matching Investor Opinion

May 07
Stevanato Group S.p.A.'s (NYSE:STVN) Share Price Matching Investor Opinion

Stevanato Group's (NYSE:STVN) Solid Earnings May Rest On Weak Foundations

Mar 15
Stevanato Group's (NYSE:STVN) Solid Earnings May Rest On Weak Foundations

Stevanato: Destocking And Valuation Risk (Rating Downgrade)

Mar 12

Is Stevanato Group S.p.A. (NYSE:STVN) Expensive For A Reason? A Look At Its Intrinsic Value

Feb 09
Is Stevanato Group S.p.A. (NYSE:STVN) Expensive For A Reason? A Look At Its Intrinsic Value

Stevanato: Guidance Reiterated And Supportive Revenue Growth

Nov 22

Is Stevanato Group S.p.A. (NYSE:STVN) Worth US$31.6 Based On Its Intrinsic Value?

Oct 22
Is Stevanato Group S.p.A. (NYSE:STVN) Worth US$31.6 Based On Its Intrinsic Value?

Stevanato: Secular Tailwinds In Biologics Support Downstream Demand

Sep 15

Stevanato Group: Undeniable Quality, But Lacking Upside

Jun 14

Stevanato Group S.p.A. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next

Mar 05
Stevanato Group S.p.A. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next

Stevanato Group and Transcoject to provide pre-fillable syringe polymer options for pharma

Jan 24

There's Reason For Concern Over Stevanato Group S.p.A.'s (NYSE:STVN) Price

Dec 28
There's Reason For Concern Over Stevanato Group S.p.A.'s (NYSE:STVN) Price

Stevanato Group Non-GAAP EPS of $0.14 beats by $0.01, revenue of $245.3M in-line

Nov 08

An Intrinsic Calculation For Stevanato Group S.p.A. (NYSE:STVN) Suggests It's 49% Undervalued

Aug 01
An Intrinsic Calculation For Stevanato Group S.p.A. (NYSE:STVN) Suggests It's 49% Undervalued

A Look At The Intrinsic Value Of Stevanato Group S.p.A. (NYSE:STVN)

Apr 19
A Look At The Intrinsic Value Of Stevanato Group S.p.A. (NYSE:STVN)

Kazanç ve Gelir Büyüme Tahminleri

NYSE:STVN - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (EUR Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20261,303185893378
12/31/20251,1751463429210
12/31/20241,096118-11520410
9/30/20241,094115-187122N/A
6/30/20241,088123-257138N/A
3/31/20241,083136-276140N/A
12/31/20231,085146-337105N/A
9/30/20231,057149-268155N/A
6/30/20231,031147-216117N/A
3/31/20231,010143-182135N/A
12/31/2022984143-140103N/A
9/30/2022924139-11499N/A
6/30/2022893122-78121N/A
3/31/2022863125-13133N/A
12/31/202184413420133N/A
9/30/202181812332139N/A
6/30/202176112172171N/A
3/31/202171810877171N/A
12/31/20206627960156N/A
12/31/201953739-3143N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: STVN 'nin tahmini kazanç büyümesi (yıllık 20.3% ) tasarruf oranının ( 2.6% ) üzerindedir.

Kazançlar ve Piyasa: STVN şirketinin kazançlarının (yıllık 20.3% ) US pazarından (yıllık 15.4% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: STVN şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artması bekleniyor.

Gelir ve Pazar: STVN şirketinin gelirinin (yıllık 8% ) US pazarından (yıllık 9% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Geliri: STVN şirketinin gelirinin (yıllık 8% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: STVN 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 11.5 %).


Büyüyen şirketleri keşfedin